Did You Know?

Editor’s Picks

Latest News

First Parkinson’s Patients Treated in Landmark Phase 2 Trial of Dapansutrile – Expanding a Leading Oral NLRP3 Inhibitor into Neurological Diseases

NEW YORK, March 24, 2026 /PRNewswire/ -- Olatec Therapeutics, Inc. ("Olatec"), developing one of the most clinically advanced specific oral...

Vella Bioscience Reveals Bold Rebrand – An Unapologetic Approach to Championing Women’s Sexual Vitality and Hormonal Wellness

Leading with plant-powered, clinical-grade innovation, Vella reintroduces Meltwater™ and Everslide™ to further its mission with greater clarity and differentiationNEW YORK,...

error: Content is protected !!